Skip to main content
. 2022 Jul 18;12(13):5710–5726. doi: 10.7150/thno.71832

Figure 7.

Figure 7

cTBS enhanced FGF2 expression in the peri-infarct zone after PT stroke. (A) (a-d) Double labeling of FGF-2 (green) and GFAP (red) in peri-infarct zone 6 days after PT stroke. Note FGF-2 immunoreactivity in astrocytes (merged yellow), whereas FGF2 appeared also associated with mature neurons and other cellular types (d, big round neuron-like cells and oligodendrocyte-like cells). (B) (a,b) Representative Western blots and quantitative analyses of FGF2 expression in peri-infarct proteins 6 days after PT stroke. Magnification: ×40, scale bar: 10 μm. Data are mean ± SE from 4-7 animals in each group. *P < 0.05 versus Ctl, #P < 0.05 versus PT group without cTBS treatment.